Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis b immune globulin posttransplant

Annals of Surgery

Volumn 226, Issue 3, 1997, Pages 356-368

  Tchervenkov, Jean I ^a,b   Joseph Lector, A ^a   Barkun, Jeffrey S ^a   Sherker, Avrell ^a   Forbes, Clark D ^a   Elias, Nahel ^a   Cantarovich, Marcello ^a   Cleland, Paul ^a   Metrakos, Peter ^a   Meakins, Jonathan L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOPEROXIDASE STAINING; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HUMANS; IMMUNE SERA; IMMUNIZATION, PASSIVE; INTERFERON-ALPHA; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECURRENCE; SEROLOGIC TESTS; TREATMENT OUTCOME;

EID: 0031410045     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199709000-00015     Document Type: Article

References (28)

1. Demetris AJ, Jaffe R, Shehan DO, et al. Recurrent hepatitis B in liver allograft recipients: differentiation between viral hepatitis B and rejection. Am J Pathol 1986; 125:161-172.
2. Lauchart W, Muller R, Pichlmayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19:2387-2389.
3. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl JMed 1989; 321:1092-1099.
4. Todo S, Demetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B related liver disease. Hepatology 1991; 13:619-626.
5. O'Grady JG, Smith M, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver transplantation, serological and clinical implications. J Hepatol 1992; 14:104-111.
6. Davies SE, Portmann BC, O'Grady JG, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13:150-157.
7. Van Thiel DH, Wright HI, Faginoli S. Liver transplantation for hepatitis B virus associated cirrhosis: a progress report. Hepatology 1994; 20(pt 2):20S-23S.
8. Lauchart W, Muller R, Pichlmayr R. Long term immunoprophylaxis of hepatitis B virus (HBV) reinfection in recipients of human liver allografts. Transplant Proc 1987; 19:4051-4052.
9. Muller R, Gubernatis G, Parle M, et al. Liver transplantation in Hbs antigen (HBsAg) carriers: prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13:90-96.
10. Samuel D, Bismuth A, Mathieu D, et al. Passive immunoprophylaxis after liver transplantation in HBsAg positive patients. Lancet 1991; 337:813-816.
11. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329:1842-1847.
12. Wright HI, Gavaler S, Van Thiel D. Preliminary experience with n-2b Interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992; 53:121-124.
13. Rakela J, Wooten RS, Batts KP, et al. Failure of Interferon to prevent recurrent hepatitis B infection in hepatic allografts. Mayo Clin Proc 1989; 64:429-432.
14. White M, Brunt EM, Regenstein F, et al. Effect of alpha-Interferon and immune globulin therapy on hepatitis B viral infection in transplanted liver recipients (Abstract). Hepatology 1990; 12:867.
15. Lavine JE, Lake JR, Ascher NL, et al. Persistent hepatitis B virus following Interferon alpha therapy and liver transplantation. Gastroenterology 1991; 100:263-267.
16. Konig V, Hopl U, Neuhaus, et al. Long term follow up of hepatitis B virus infected recipients after orthotopic liver transplantation. Transplantation 1994; 58:553-559.
17. Devlin J, Smith HM, O'Grady JG, et al. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg positive liver recipients. J Hepatol 1994; 21:204-210.
18. Hoofnagle JH, Peters M, Müllen KD, et al. Randomized, controlled trial of recombinant human a-Interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95:1318-1323.
19. Perillo RP, Schiff ER, Davis GL, et al. A randomized controlled trial of Interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis .B. N Engl'j Med 1990; 323:295-301.
20. McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:1358-1364.
21. Marcellin P, Samuel D, Areias J, et al. Pretransplantation Interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19:6-12.
22. Bain VG, Kneteman NM, Ma MM, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62:1456-1462.
23. Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:1212-1215.
24. Bartholomew MM, Jansen RW, Jeffers, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Comment in: Lancet 1997; 349(9044):3-4.
25. Asher NL, Lake JR, Edmont J, Roberts J. Liver transplantation for hepatitis C virus related cirrhosis. Hepatology 1994; 20:S24-S27.
26. Ferrell LD, Wright TL, Roberts J, et al. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16:865-876.
27. Shiffman ML, Contos MJ, Luketic VA. Biochemical and histological evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation 1994; 57:526-532.
28. Boker KHW, Dalley G, Bahr MJ, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203-210.